New Lung-Box device could save more transplant organs

NCT ID NCT02234128

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a device called the Toronto EVLP System that keeps donated lungs warm and breathing outside the body. The goal was to see if it is safe to extend the time doctors can preserve and check the lungs before transplant. 118 adults waiting for a lung transplant took part. Researchers compared their outcomes to standard transplant procedures, focusing on survival and lung function after 30 days.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Toronto EVLP System (device that keeps donor lungs warm and breathing outside the body)
What this could lead to
If successful, this could allow more donor lungs to be used for transplant by giving doctors more time to assess them safely.
What could go wrong
This is a safety study, not a test of cure. The device may not improve outcomes, and there are standard risks of lung transplant like organ rejection or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • Duke University Health System

    Durham, North Carolina, 27705, United States

  • Inova Fairfax Medical Campus

    Falls Church, Virginia, 22042, United States

  • Loyola University Medical Center

    Chicago, Illinois, 60153, United States

  • Mayo Clinic Jacksonville

    Jacksonville, Florida, 32224, United States

  • UPMC

    Pittsburgh, Pennsylvania, 15213, United States

  • University of Maryland Medical Center

    Baltimore, Maryland, 21201, United States

  • University of Michigan Health System

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.